Published in Science on October 07, 1994
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev (1997) 10.52
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
When less is more: gene loss as an engine of evolutionary change. Am J Hum Genet (1999) 5.32
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet (1998) 5.24
Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest (2002) 4.97
Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest (2005) 2.50
A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest (1995) 2.48
Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut (2003) 2.37
Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation. PLoS Genet (2010) 2.14
Comparative genomics search for losses of long-established genes on the human lineage. PLoS Comput Biol (2007) 2.07
De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet (1997) 2.05
Structural flexibility of the G alpha s alpha-helical domain in the beta2-adrenoceptor Gs complex. Proc Natl Acad Sci U S A (2011) 2.03
Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med (2005) 1.79
Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol (1996) 1.74
Targets of balancing selection in the human genome. Mol Biol Evol (2009) 1.69
Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. Cell Host Microbe (2013) 1.61
Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation. J Physiol (2009) 1.58
Functional regulation of cystic fibrosis transmembrane conductance regulator-containing macromolecular complexes: a small-molecule inhibitor approach. Biochem J (2011) 1.55
Crossing the line: selection and evolution of virulence traits. PLoS Pathog (2006) 1.49
Calcium-sensing receptor abrogates secretagogue- induced increases in intestinal net fluid secretion by enhancing cyclic nucleotide destruction. Proc Natl Acad Sci U S A (2006) 1.48
Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli. Infect Immun (2004) 1.45
The great opportunity: Evolutionary applications to medicine and public health. Evol Appl (2008) 1.43
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet (1996) 1.38
CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners. Integr Biol (Camb) (2010) 1.32
Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28
Reversible silencing of CFTR chloride channels by glutathionylation. J Gen Physiol (2005) 1.22
Worldwide genetic analysis of the CFTR region. Am J Hum Genet (2000) 1.18
Deletion of the chloride transporter Slc26a9 causes loss of tubulovesicles in parietal cells and impairs acid secretion in the stomach. Proc Natl Acad Sci U S A (2008) 1.18
Physiology of epithelial chloride and fluid secretion. Cold Spring Harb Perspect Med (2012) 1.16
The "Goldilocks effect" in cystic fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse. BMC Genet (2004) 1.13
Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents. Mol Pharmacol (2004) 1.11
Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol (2004) 1.09
Nanomolar CFTR inhibition by pore-occluding divalent polyethylene glycol-malonic acid hydrazides. Chem Biol (2008) 1.09
Evidence for hitchhiking of deleterious mutations within the human genome. PLoS Genet (2011) 1.08
Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C. Am J Hum Genet (2012) 1.08
Mutual enhancement of virulence by enterotoxigenic and enteropathogenic Escherichia coli. Infect Immun (2006) 1.07
Convective washout reduces the antidiarrheal efficacy of enterocyte surface-targeted antisecretory drugs. J Gen Physiol (2013) 1.07
Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in murine cell line. J Physiol (2000) 1.05
Evaluating candidate agents of selective pressure for cystic fibrosis. J R Soc Interface (2007) 1.04
Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity. Proc Natl Acad Sci U S A (1995) 1.03
A unified view of cystic fibrosis transmembrane conductance regulator (CFTR) gating: combining the allosterism of a ligand-gated channel with the enzymatic activity of an ATP-binding cassette (ABC) transporter. J Biol Chem (2011) 1.03
A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. Genes Immun (2009) 1.01
CFTR chloride channels are regulated by a SNAP-23/syntaxin 1A complex. Proc Natl Acad Sci U S A (2002) 1.01
Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas. Future Med Chem (2012) 1.00
Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med Genet (2011) 1.00
Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis. Bioorg Med Chem (2008) 0.98
The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J Physiol (1995) 0.98
Three-dimensional reconstruction of human cystic fibrosis transmembrane conductance regulator chloride channel revealed an ellipsoidal structure with orifices beneath the putative transmembrane domain. J Biol Chem (2008) 0.97
Cse1l is a negative regulator of CFTR-dependent fluid secretion. Curr Biol (2010) 0.96
MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups. J Clin Invest (1997) 0.96
Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet (2003) 0.95
Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion. J Biol Chem (2011) 0.94
Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR). Hum Genet (2005) 0.93
Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics (2007) 0.93
Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J (2008) 0.92
RAB11-mediated trafficking in host-pathogen interactions. Nat Rev Microbiol (2014) 0.92
Can a place of origin of the main cystic fibrosis mutations be identified? Am J Hum Genet (2001) 0.90
Evolution in health and medicine Sackler colloquium: Evolution and public health. Proc Natl Acad Sci U S A (2009) 0.90
Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia. J Bioenerg Biomembr (2006) 0.90
Inflammation and CFTR: might neutrophils be the key in cystic fibrosis? Mediators Inflamm (1999) 0.89
Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet (2000) 0.89
A cluster of negative charges at the amino terminal tail of CFTR regulates ATP-dependent channel gating. J Physiol (2001) 0.89
Deletion of a single allele of the Pex11β gene is sufficient to cause oxidative stress, delayed differentiation and neuronal death in mouse brain. Dis Model Mech (2011) 0.88
Studies of the mechanism of action of the aerolysin-like hemolysin of Aeromonas sobria in stimulating T84 cells to produce cyclic AMP. Infect Immun (2003) 0.88
Myosin Ia is required for CFTR brush border membrane trafficking and ion transport in the mouse small intestine. Traffic (2012) 0.87
A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population. Am J Hum Genet (2002) 0.87
Three charged amino acids in extracellular loop 1 are involved in maintaining the outer pore architecture of CFTR. J Gen Physiol (2014) 0.86
Toxin mediated diarrhea in the 21 century: the pathophysiology of intestinal ion transport in the course of ETEC, V. cholerae and rotavirus infection. Toxins (Basel) (2010) 0.85
Identification of resveratrol oligomers as inhibitors of cystic fibrosis transmembrane conductance regulator by high-throughput screening of natural products from chinese medicinal plants. PLoS One (2014) 0.85
Cystic fibrosis in adults. From researcher to practitioner. West J Med (1996) 0.84
Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents. Br J Pharmacol (1999) 0.83
Compartmentalization of cyclic nucleotide signaling: a question of when, where, and why? Pflugers Arch (2013) 0.83
Human gene mutation in pathology and evolution. J Inherit Metab Dis (2002) 0.82
Characterization of CFTR High Expresser cells in the intestine. Am J Physiol Gastrointest Liver Physiol (2013) 0.81
Cell-specific effects of luminal acid, bicarbonate, cAMP, and carbachol on transporter trafficking in the intestine. Am J Physiol Gastrointest Liver Physiol (2012) 0.81
TGF-β-induced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice. Am J Physiol Lung Cell Mol Physiol (2015) 0.81
Evolutionary molecular medicine. J Mol Med (Berl) (2012) 0.81
Genetic epidemiology and preventive healthcare in multiethnic societies: the hemoglobinopathies. Int J Environ Res Public Health (2014) 0.81
Gastrointestinal Manifestations of Cystic Fibrosis. Dig Dis Sci (2015) 0.81
Immunological alterations mediated by adenosine during host-microbial interactions. Immunol Res (2011) 0.81
Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage? Eur J Hum Genet (2008) 0.81
Case studies in cholera: lessons in medical history and science. Yale J Biol Med (2001) 0.81
Protection against cholera. Science (1995) 0.80
Calcium-sensing receptor: A new target for therapy of diarrhea. World J Gastroenterol (2016) 0.80
Mannose-binding lectin and maladies of the bowel and liver. World J Gastroenterol (2006) 0.79
Microfluidics platform for measurement of volume changes in immobilized intestinal enteroids. Biomicrofluidics (2014) 0.79
Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages. Autophagy (2016) 0.79
delta F508 in cystic fibrosis: willing but not able. Arch Dis Child (1997) 0.78
Mild CFTR mutations and genetic predisposition to lactase persistence in cystic fibrosis. Eur J Hum Genet (2011) 0.78
Decreased function of survival motor neuron protein impairs endocytic pathways. Proc Natl Acad Sci U S A (2016) 0.77
In vitro analysis of PDZ-dependent CFTR macromolecular signaling complexes. J Vis Exp (2012) 0.77
ATP and AMP mutually influence their interaction with the ATP-binding cassette (ABC) adenylate kinase cystic fibrosis transmembrane conductance regulator (CFTR) at separate binding sites. J Biol Chem (2013) 0.77
Murine and human CFTR exhibit different sensitivities to CFTR potentiators. Am J Physiol Lung Cell Mol Physiol (2015) 0.77
Longevity and plasticity of CFTR provide an argument for noncanonical SNP organization in hominid DNA. PLoS One (2014) 0.77
Common CFTR gene variants influence body composition and survival in rural Ghana. Hum Genet (2009) 0.77
Who's really in control: microbial regulation of protein trafficking in the epithelium. Am J Physiol Cell Physiol (2013) 0.76
Potent stimulation and inhibition of the CFTR Cl(-) current by phloxine B. Br J Pharmacol (2000) 0.76
Activation of AMPK inhibits cholera toxin stimulated chloride secretion in human and murine intestine. PLoS One (2013) 0.76
Brca1 controls homology-directed DNA repair. Mol Cell (1999) 7.82
Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell (1998) 6.72
CFTR as a cAMP-dependent regulator of sodium channels. Science (1995) 6.50
An animal model for cystic fibrosis made by gene targeting. Science (1992) 5.75
Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem (2001) 5.74
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell (1999) 4.93
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A (2001) 4.58
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem (2000) 4.49
Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet (1992) 4.12
Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature (1992) 3.50
Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev (1999) 3.41
Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest (1986) 3.36
Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science (1983) 3.31
Coordinated clearance of periciliary liquid and mucus from airway surfaces. J Clin Invest (1998) 3.30
Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med (1991) 3.25
Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol (1998) 3.25
Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet (1996) 2.99
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science (1992) 2.98
Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem (2000) 2.86
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest (2001) 2.86
A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med (1990) 2.83
An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem (1998) 2.80
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet (1992) 2.79
A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A (1987) 2.77
Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature (1994) 2.57
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature (1997) 2.56
Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell (1993) 2.54
Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br J Pharmacol (1991) 2.53
Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice. Proc Natl Acad Sci U S A (1994) 2.53
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci U S A (1994) 2.48
Retracted BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science (1998) 2.48
Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest (1997) 2.47
Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem (2000) 2.44
Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J Immunol (1985) 2.43
Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem (1992) 2.42
The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell (2001) 2.42
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
Expression and localization of epithelial aquaporins in the adult human lung. Am J Respir Cell Mol Biol (2001) 2.36
Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science (1992) 2.36
Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther (2000) 2.34
Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum. Am Rev Respir Dis (1993) 2.31
Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A (1987) 2.31
The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol (2001) 2.28
A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J Immunol (1999) 2.26
Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med (1999) 2.25
Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells. Proc Natl Acad Sci U S A (2001) 2.17
Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A (1988) 2.12
Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50. J Cell Biol (1999) 2.11
Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proc Natl Acad Sci U S A (1991) 2.04
Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells. Mol Pharmacol (1991) 2.00
Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J Biol Chem (1997) 1.99
Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest (2001) 1.99
Isolation of HLA locus-specific DNA probes from the 3'-untranslated region. Proc Natl Acad Sci U S A (1984) 1.93
CFTR is a conductance regulator as well as a chloride channel. Physiol Rev (1999) 1.90
In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther (1995) 1.86
Osmotic water permeabilities of cultured, well-differentiated normal and cystic fibrosis airway epithelia. J Clin Invest (2000) 1.82
Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol (1995) 1.81
Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice. Am J Physiol (1994) 1.79
Altered intestinal chloride transport in cystic fibrosis. FASEB J (1988) 1.78
Benign missense variations in the cystic fibrosis gene. Am J Hum Genet (1990) 1.67
Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. Am J Physiol (1993) 1.66
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest (1999) 1.66
Chloride secretory response of cystic fibrosis human airway epithelia. Preservation of calcium but not protein kinase C- and A-dependent mechanisms. J Clin Invest (1989) 1.62
Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics. J Biol Chem (1997) 1.61
Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci U S A (1994) 1.59
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci U S A (2001) 1.58
Regional differences in airway surface liquid composition. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.58
Role of gammaENaC subunit in lung liquid clearance and electrolyte balance in newborn mice. Insights into perinatal adaptation and pseudohypoaldosteronism. J Clin Invest (1998) 1.55
Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc Natl Acad Sci U S A (1990) 1.53
Cystic fibrosis transmembrane regulator-independent release of ATP. Its implications for the regulation of P2Y2 receptors in airway epithelia. J Biol Chem (1998) 1.53
Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice. J Exp Med (1997) 1.53
CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship. Nature (1993) 1.52
Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody. Nat Biotechnol (1999) 1.51
Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y(2) receptor (-/-) mice. J Biol Chem (1999) 1.51
Intracellular Cl- activity and cellular Cl- pathways in cultured human airway epithelium. Am J Physiol (1989) 1.51
Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol Cell Biol (1999) 1.50
Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium. Pediatr Res (1986) 1.49
Culture of human nasal epithelial cells on collagen matrix supports. A comparison of bioelectric properties of normal and cystic fibrosis epithelia. Am Rev Respir Dis (1985) 1.47
Activation of an apical Cl- conductance by Ca2+ ionophores in cystic fibrosis airway epithelia. Am J Physiol (1989) 1.46
Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest (1998) 1.46
Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest (1989) 1.46
Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J Virol (2000) 1.45
Airway transepithelial electric potential in vivo: species and regional differences. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.44
Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am Rev Respir Dis (1981) 1.43
Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol (2000) 1.42